Where does Cellens's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cellens's 3 recorded funding rounds.

Premier Alternatives

Cellens

Decision/Risk Analysis · Boston, MA · Founded 2019 · Privately Held (backing)

Developer of a cell surface scanning platform designed to assist oncologists in performing noninvasive detection of bladder cancer. Cellens is based in Boston, MA and was founded in 2019. It was valued at $19.4 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $7.5 million across 3 recorded rounds; the latest was a $6.4 million early-stage round in Aug 2025.

PMV mark · valuation

$19.4M

Oct 2026

Priced at

its early-stage round

Aug 2025

Total raised

$7.5M

Last round

Early Stage VC

Aug 2025

Cap table — not yet on record

Cellens's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Cellens with a free account

·The complete investor list: 19 names
·Watch Cellens: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Cellens

Where does Cellens's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cellens's 3 recorded funding rounds.